Archive of all the blogs posted
Showing 12 articles this page
FY26 saw 108 mainboard IPOs raise ₹1,75,186 crore - a record. Yet 71 of those IPOs are below their issue price. Here is the full performance breakdown, subscription data, and what it means for investo
Read Full
Omnitech Engineering IPO review 2026: issue size, price band, lot size, order book, business model, financials, valuation (EPS/P-E), use of proceeds for new facilities, key risks, and who it may suit.
Read Full
PNGS Reva Diamond Jewellery IPO review 2026: price band, lot size, business model (FOCO/FOFO/COCO), financials, valuation, use of proceeds for 15 new stores, key risks, and who it may suit. Educationa
Read Full
Gaudium IVF IPO review covering business model, financials, valuation, GMP, use of proceeds, risks, and who this Gaudium IVF stock may suit. A neutral, data-backed analysis for retail investors.
Read Full
Fractal Analytics IPO review covering business model, financials, valuation, GMP, use of proceeds, risks, and who this AI-led company may suit. A neutral, data-backed analysis for retail investors.
Read Full
Shadowfax IPO review covering business model, financials, valuation, GMP, peer comparison with Blue Dart and Delhivery, key risks, and who this logistics IPO may suit.
Read Full
Detailed Amagi Media Labs IPO review covering business model, financials, GMP, risks, use of proceeds, and who this ad-tech IPO may suit.
Read Full
BCCL IPO review with price band, GMP snapshot, financials, key ratios, risks, timeline, and what drives earnings in a cyclical PSU coking coal business.
Read Full
India has raised record IPO funds, yet private sector capex remains weak. A closer look at how IPO money is actually used explains the gap.
Read Full
ICICI Prudential AMC IPO opens Dec 12–16. Check GMP, financials, strengths, risks, valuations, lot size, timeline, and full investor-focused analysis.
Read Full
Meesho and Aequs saw huge IPO demand from retail investors despite being loss-making. Is the low IPO price creating a false sense of safety? Here’s the breakdown.
Read Full
Corona Remedies IPO opens Dec 8–10. Explore GMP trends, financials, strengths, risks, valuations, and complete IPO details in this investor-focused review.
Read Full